Skip to main content
Clinical Trials/NCT00364702
NCT00364702
Completed
Phase 2

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Shaare Zedek Medical Center1 site in 1 country40 target enrollmentAugust 2006
ConditionsADHD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
ADHD
Sponsor
Shaare Zedek Medical Center
Enrollment
40
Locations
1
Primary Endpoint
Virtual Reality program test results
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Using a virtual reality program in screening and treatment of ADHD.

Detailed Description

Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADHD will use the program with and without methylphenidate(1 mg/kg). Their results will be compared to a control group. Parental consent will be obtained.

Registry
clinicaltrials.gov
Start Date
August 2006
End Date
July 2007
Last Updated
14 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination IQ\>80

Exclusion Criteria

  • ABNORMAL NEUROLOGICAL STATUS

Outcomes

Primary Outcomes

Virtual Reality program test results

Study Sites (1)

Loading locations...

Similar Trials